Oral Health and Arthritis: The Citrullination Link and What It Means

Most articles connecting oral health to a systemic condition rest on the same general argument: gum disease causes chronic inflammation, chronic inflammation is bad for you, therefore gum disease contributes to the condition in question. It is a reasonable argument but it is non-specific, and it applies equally to almost any inflammatory disease.

Rheumatoid arthritis is different. Here there is a specific, named biochemical mechanism linking one oral bacterium to the central immunological event of the disease, and it is worth understanding properly.

Rheumatoid arthritis is an autoimmune condition. The immune system produces antibodies against the body's own tissue, and the resulting inflammation of the synovial lining of joints causes pain, swelling, stiffness and, over time, erosion of bone and cartilage.

It is distinct from osteoarthritis, which is a wear-related degeneration of joint cartilage without a primary autoimmune driver. The connection discussed here applies primarily to rheumatoid arthritis.

The defining immunological feature of rheumatoid arthritis is the presence of antibodies against citrullinated proteins — anti-CCP antibodies. These are highly specific to the condition and can appear in the blood years before joint symptoms begin.

Citrullination is a normal, ordinary chemical modification. An enzyme converts the amino acid arginine within a protein into citrulline. It happens continuously in healthy tissue as part of normal turnover, particularly during cell death and inflammation.

The problem in rheumatoid arthritis is not that citrullination occurs. It is that the immune system, in susceptible individuals, begins to recognise citrullinated proteins as foreign and mounts an antibody response against them. Once that response is established, any tissue containing citrullinated proteins becomes a target — including joint tissue.

The question that has occupied researchers is what triggers the initial loss of tolerance. Something has to present citrullinated proteins to the immune system in a context that breaks tolerance, and there has been longstanding interest in whether that first event happens somewhere other than the joint.

Porphyromonas gingivalis is a keystone bacterium in periodontitis. It has an unusual property: it is the only known prokaryote that produces a peptidylarginine deiminase enzyme — the enzyme class that performs citrullination.

This matters because the bacterial version behaves differently from the human one. It citrullinates proteins at the C-terminal position, producing citrullinated peptides that human enzymes do not generate. It can citrullinate both bacterial and human proteins, including fibrinogen and alpha-enolase — two of the main targets of anti-CCP antibodies in rheumatoid arthritis.

The proposed sequence is therefore: chronic periodontitis creates an environment where this bacterium is abundant; the bacterial enzyme generates novel citrullinated peptides in an inflamed tissue with an ulcerated lining and direct vascular access; the immune system encounters them and, in genetically susceptible individuals, loses tolerance; the resulting antibodies subsequently cross-react with citrullinated proteins in joints.

Genetic susceptibility is a necessary part of the story. The strongest genetic association with rheumatoid arthritis is the shared epitope in the HLA-DRB1 region, which affects how citrullinated peptides are presented to the immune system. The hypothesis is not that gum disease causes arthritis in anyone; it is that it may be one trigger in people already predisposed.

A second oral bacterium, Aggregatibacter actinomycetemcomitans, has been implicated by a different mechanism — a toxin that causes neutrophils to rupture and release their own citrullinating enzymes, producing a citrullination pattern resembling that found in rheumatoid joints.

Stronger than for most oral-systemic claims, but still short of proven.

Supporting it: people with rheumatoid arthritis have higher rates of periodontitis than the general population, and vice versa. Antibodies to P. gingivalis are more common in people with rheumatoid arthritis, and in some studies precede disease onset. The enzymatic mechanism is demonstrated in the laboratory. Several small studies have reported that periodontal treatment reduces disease activity scores in rheumatoid arthritis.

Against it, or complicating it: the periodontal treatment studies are small and heterogeneous, with inconsistent results. The two conditions share risk factors, notably smoking, which is itself a strong risk factor for anti-CCP positive rheumatoid arthritis and also a major risk factor for periodontitis — a substantial confounder. And the direction of the association is difficult to establish, since the arthritis itself contributes to gum disease for reasons set out below.

Our article on whether poor oral health influences common chronic diseases covers how to weigh these associations generally.

This part is not hypothetical, and for anyone living with the condition it is more immediately relevant.

Hand and wrist involvement. Rheumatoid arthritis commonly affects the small joints of the hands. Grip strength, pinch grip and fine wrist rotation are precisely the movements toothbrushing and flossing require. Morning stiffness is worst at the time most people brush.

Dry mouth. Secondary Sjögren's syndrome occurs in a significant proportion of people with rheumatoid arthritis, reducing salivary flow substantially. Saliva buffers acid, clears debris and carries antimicrobial proteins; without it, decay rates rise sharply and gum inflammation worsens. Several arthritis medications also reduce salivary flow.

Jaw joint involvement. The temporomandibular joint is a synovial joint and can be affected like any other, producing pain, restricted opening and in long-standing cases changes to the bite. Restricted opening also makes both home cleaning and dental treatment harder. Our page on TMJ treatment covers management.

Medication interactions with dental care. Methotrexate, biologic agents and long-term corticosteroids all affect dental management. Immunosuppression affects healing and infection risk; corticosteroids affect bone. Some biologics are paused around surgical procedures. None of this rules out dental treatment, but it needs to be planned with knowledge of the medication, and your dental team needs an accurate and current list.

Fatigue. Often the most disabling symptom, and it affects daily routines including oral hygiene.

Modify the handle, not the technique. Building up a toothbrush handle with foam tubing, a bicycle grip or a tennis ball makes it graspable with a weak or painful hand.

Use an electric toothbrush. The brush does the movement, so the hand only has to hold and guide it. The wider handle also helps. This is one of the clearest wins for anyone with hand involvement.

Switch from floss to interdental brushes. Floss requires fine bimanual coordination. Interdental brushes with a long handle require far less. A water flosser is another option where dexterity is limited. Our article on flossing technique covers the alternatives.

Brush at your best time of day. If mornings are stiff, move the main thorough clean to the evening or later in the morning.

Manage dry mouth actively. Saliva substitutes, frequent sips of water, sugar-free gum where the jaw permits, avoiding alcohol-containing mouthwashes, and high-fluoride toothpaste where decay risk is raised. Our article on how medications affect oral health covers this.

Shorten and increase the frequency of hygiene appointments. More frequent, shorter visits are often better tolerated than long ones, particularly with jaw involvement. Our article on how early detection of gum disease reduces long-term costs covers the value of the shorter interval.

Tell your dental team and your rheumatology team about each other. Each needs to know what the other is doing.

Bleeding gums are not a normal consequence of arthritis and should not be dismissed as one. Our article on why gums bleed when brushing covers the causes, and our article on managing bleeding gums covers what to do.

Increasing gum recession, loose teeth, persistent bad taste or gum swelling all warrant assessment. Our article on how long gum disease treatment takes covers the process, and gum disease treatment is the starting point.

• Rheumatoid arthritis is defined immunologically by antibodies against citrullinated proteins.

• P. gingivalis is the only known bacterium producing a citrullinating enzyme, generating peptides human enzymes do not make.

• The hypothesis is that periodontitis may trigger loss of immune tolerance in genetically susceptible people, not that it causes arthritis generally.

• Shared risk factors, particularly smoking, confound the association; treatment studies are small and inconsistent.

• Arthritis affects oral health in well-established ways: hand involvement, dry mouth, jaw joint disease and medication effects.

• Adapted brush handles, electric brushes, interdental brushes and active dry mouth management make the largest practical difference.

If arthritis is making dental care harder, or you have noticed bleeding or receding gums, an assessment can establish what is needed and what adaptations would help. You can contact our team, and treatment may involve gum disease treatment alongside regular dental hygiene appointments.

This article is provided for general information only and does not constitute dental or medical advice. The relationship between periodontitis and rheumatoid arthritis is an area of ongoing research and no causal link has been established. Nothing here should be taken as a claim that dental treatment treats or influences arthritis. Discuss your arthritis and its management with your medical team.

Next review due: 18 August 2027